study question: What is the percentage of overtreatment, i.e. fertility treatment started too early, in couples with unexplained infertility who were eligible for tailored expectant management?
Introduction
Over recent decades, the use of medically assisted reproduction (MAR) has increased enormously (Ferraretti et al., 2013) . At a time where health care costs have increased greatly, it becomes even more important that fertility care is not only clinically effective and safe, but also cost-effective (Leavitt, 2001; Appleby, 2012) . Regrettably, many MAR cycles are performed without evidence that such treatment is indicated or likely to be effective (Bensdorp et al., 2007; Steures et al., 2008; Veltman-Verhulst et al., 2012) . Despite the growing use of MAR, the pregnancy and delivery rates have not increased over the last few years (Ferraretti et al., 2013) . Due to the increasing costs not all societies can bear the costs of fertility care any longer (Chambers et al., 2012) . Only a few societies fully reimburse fertility care (Jones et al., 2011) . One important way to minimize societal costs, without a negative impact on couples with infertility, is to prevent overtreatment in infertile couples by reducing unnecessary MAR and related costs (van den Boogaard et al., 2013) .
As well as the economic aspects, the reduction of unnecessary MAR is important to avoid exposing couples to the risks, complications and burdens associated with invasive treatments, which will not improve the chance of conception or decrease the time to pregnancy (Verhaak et al., 2002; Helmerhorst et al., 2004; Steures et al., 2008; Verberg et al., 2008; Custers et al., 2012) .
To achieve a reduction of unnecessary MAR, it is important to distinguish couples who would actually benefit from MAR from the couples who do not, e.g. by the use of prognostic models (Brandes et al., 2011; Van Geloven et al., 2013) . In infertile couples where no underlying cause of the infertility is found, the chances of a spontaneous pregnancy can be calculated with the Hunault prognostic model (Hunault et al., 2004; van der Steeg et al., 2007) . If the chance of a natural conception within 1 year is good, meaning 30% or higher, fertility treatment does not increase the chance of an ongoing pregnancy compared with an expectant management of 6-12 months (tailored expectant management, TEM) (Steures et al., 2008; Custers et al., 2012) . Therefore, for couples with unexplained infertility and a good prognosis, TEM is equally as effective as MAR and it does not expose couples to all the associated risks. Furthermore, the increasing costs of fertility care are making it necessary to improve the cost-effectiveness of current care. Therefore, current European guidelines recommend TEM for 6 -12 months (e.g. National Institute of Clinical Excellence (NICE) and the Dutch Society for Obstetrics and Gynaecology (NVOG, www.nvog.nl)). Adherence to these guidelines with regard to TEM helps to prevent overtreatment.
However, previous studies have shown that implementation of TEM is limited by both professional and patient-related factors (van den Boogaard et al., 2011) . The main barriers amongst professionals are limited knowledge about prognostic models and TEM, and difficulties in counselling couples for TEM. Barriers on the patient level include a lack of confidence in natural conception and not understanding the reason for expectant management. Furthermore, previous research in fertility care as well as other fields of care showed that a variety of patient and clinic characteristics can explain poor adherence to guidelines (Fine et al., 2002; Schouten et al., 2005; Hermens et al., 2011; van den Boogaard et al., 2011 van den Boogaard et al., , 2012 . However, evidence for characteristics related to TEM is scarce. More knowledge on these characteristics is important to help tailoring interventions to minimize overtreatment.
This study aims to assess overtreatment (i.e. started MAR too early) in couples with unexplained infertility that were eligible for TEM.
Furthermore, we will evaluate the characteristics on patient and clinic level associated with overtreatment. The study will provide more insight in current care and will help to develop a strategy to prevent couples from starting fertility treatment too early in the future.
Materials and Methods

Study design
We conducted a retrospective cohort study in 25 Dutch clinics using medical records and a professionals' questionnaire. Furthermore, we evaluated a possible selection bias between responders and non-responders by conducting semi-structured telephone interviews with non-responders in six clinics.
Ethical approval
The institutional ethics committee of Radboud university medical center provided ethical approval for this study (CMO no. 2012/130) .
Setting
Dutch fertility care
In Dutch fertility care, referral of infertile couples to secondary or tertiary care is mainly done by general practitioners (GPs), fertility doctors (medical doctors specialized in assisted reproduction), medical specialists, or on the patients' own initiative. Initial fertility work up, ovulation induction (OI) and intrauterine insemination (IUI) are carried out in all Dutch clinics. Intermediate clinics can start and monitor the IVF and ICSI treatment. The laboratory phase of IVF and embryo transfer has to be carried out in a fully licensed fertility clinic. To ensure that the 25 clinics were representative for Dutch fertility care, we selected six fully licensed fertility clinics, eleven intermediate fertility clinics and eight clinics with no IVF facilities, spread across the country, to participate. In the Netherlands, the compulsory basic insurance coverage fully reimburses all treatment cycles of OI and IUI, as well as a maximum of three IVF or ICSI cycles.
Dutch Network Guideline on Infertility
The Dutch Network Guideline on Infertility makes specific recommendations on TEM (www.nvog.nl). These recommendations are based on three steps.
The first step is correctly diagnosing and identifying couples that are eligible for TEM, i.e. calculating the chance of a natural conception within 1 year for couples with unexplained infertility with the prognostic model of Hunault (Hunault et al., 2004) . The prognostic model takes four mandatory factors into account, female age (years), duration of infertility (years), type of infertility (primary/secondary) and quality of semen (percentage progressive motile sperm). Three factors are optional, referral status (GP/own initiative/professional), cervical factor (post-coital test positive/negative) and diagnosis of one-sided tubal pathology (yes/no). Professionals can have access to the prognostic model via a patient website (www.freya.nl), through local electronic patient file systems, or with the use of a paper version.
The second step is to recommend TEM for at least 6 -12 months for couples with a good prognosis (.30% in 1 year) after finalizing the fertility work up.
The third step is to adhere to the advised expectant period of at least 6 months.
The first two steps have to be done by the professional. They have to correctly diagnose and identify the couple as being eligible for TEM, and subsequently have to advise an expectant management of at least 6 -12 months. However, the third step is dependent on both the professional and the couple. If TEM is advised by the professionals, the guideline recommends that the couple is educated on the most fertile period, optimal coital frequency and healthy lifestyle factors to optimize the couples' chance of natural conception.
Study population
Couples were eligible to participate in our study when they have been diagnosed with unexplained infertility and had a good prognosis of a natural conception within 1 year based on Hunault's prediction model (Hunault et al., 2004) . According to the Dutch fertility guidelines, the diagnosis of unexplained infertility is given if the fertility work up shows no cause for the infertility or if it shows mild abnormalities that are not significant enough to obstruct a natural conception. These include a cervical factor, one-sided tubal pathology, mild male infertility (total motile sperm count [TMSC] 3 -10 million), and/or mild endometriosis (American Society of Reproductive Medicine stage I/II) (Wiersma and Nelen, 2010) . Couples with previous fertility treatments, female age over 38 years, bilateral tubal pathology, anovulation or a severe male factor (TMSC ,3 million) were excluded.
Recruitment
To assess overtreatment in current fertility care in the Netherlands, we aimed at including a broad patient cohort from the participating clinics. To include eligible participants, potential couples were selected by means of each clinics' financial DBC (Diagnosis/Treatment Combination code) registration database. In this national database, all patients undergoing diagnostics or treatment for infertility are identified with a specific Fertility-code for new patients (F11-code). It is not possible to distinguish patients with unexplained infertility from patients with a clear cause for their infertility with the existing databases. In order to select as many potential participants as possible we approached all couples who had an active F11-code anytime between March 2011 and February 2012. All couples were sent an informed consent form with an information letter, including five questions regarding the exclusion criteria, i.e. What is the age of the woman?, Have you had fertility treatment before 2011?, Are both Fallopian tubes occluded?, Do you usually have a regular menstrual cycle between 25 and 35 days (without medication)?, Have you been treated with ICSI since 2011?. If couples had no exclusion criteria based on these five questions, they were invited to participate in this study and give informed consent for accessing their medical record. Non-responders were sent one reminder after 3 -4 weeks.
Non-responders
To evaluate a possible selection bias we compared responders to nonresponders in six clinics. We selected six clinics with the lowest response rate, all types of fertility clinics were found to be represented (no/intermediate/full IVF facilities) and the clinics were spread across the country. A sample size of 15% of the non-responders in each clinic is necessary to retain a representative sample (Ronmark et al., 1999) . In order to achieve this target, we decided to select a random, computer generated, sample of 20% of the nonresponders in these clinics.
Outcome measures
Overtreatment
We defined overtreatment as starting fertility treatment too early when couples exhibited unexplained infertility and had a good prognosis of a natural conception within 1 year based on Hunault's prediction model. Too early means that they started treatment within 6 months after finalizing the fertility work up (date of the evaluation with the couple). To assess the process that leads to overtreatment we extracted a set of three quality indicators, based on the three steps that are necessary to follow guideline recommendations on TEM. Overtreatment is a result of at least one, or a combination of the following quality indicators.
Quality indicators
-The first indicator is failure to diagnose correctly and identify couples who are eligible for tailored expectant management, i.e. the prognosis of a natural conception within 1 year was not calculated. -The second indicator is failure to advise the correct policy after finalizing the fertility work up, i.e. couples were not advised to undergo an expectant management of at least 6 months or couples who started fertility treatment immediately. -The third indicator is failure to complete the expectant period of at least 6 months after TEM was advised, i.e. couples were advised the correct policy but started fertility treatment within 6 months anyway.
Data collection
Overtreatment and quality indicators
Data to assess overtreatment and quality indicators were abstracted from medical records using a standardized audit form. If the couple fitted the inclusion criteria, we collected the diagnostic measures and treatment related measures. Diagnostic measures included the fertility work up outcomes (e.g. semen analysis, post-coital test, hysterosalpingography, laparoscopy), the date of fertility work up completion/date of evaluation with couple (dd/mm/yy), initial diagnosis, and if calculation of prognosis was performed (yes/no). Treatment related measures included the course of treatment that was advised after fertility work up, the date of the start of treatment (mm/ yy), treatment type and treatment outcome. We calculated the time interval between completion of fertility work up and start of treatment.
Patient and clinic characteristics
Data on patient characteristics were extracted from medical records using a standardized audit form. The patient characteristics are: female age(years), referral status (own initiative/GP/specialist), female obstetric history, type of infertility for the couple (primary/secondary), duration of infertility (years) and female body mass index (BMI kg/m 2 ). Furthermore, we extracted postal area code to derive the socio-economic status (SES) of the couples (obtained from the Dutch Institute for Social Research/SC based on the mean income level in a postal area code).
Data on the clinic characteristics were obtained by sending a digital questionnaire to one gynaecologist, specialized in reproductive medicine, from each participating clinic. The questionnaire was divided in two parts. The first part contained questions about the local organization of the fertility care and the second part about the information provision. Characteristics on the organization of fertility care included IVF facilities (fully licensed/intermediate/no IVF facilities), training clinic (yes/no), professional functions (e.g. fertility doctor, fertility specialized nurse, research nurse) present in the fertility team (yes/no and number), availability of a regular fertility team meeting (yes/no and frequency), mean number of fertility consultations per gynaecologist per week, and assignment of one lead physician to each infertile couple who is responsible for every in-between evaluation and decisionmaking with the couple (yes/no). Characteristics on information provision included information available on TEM for couples with unexplained infertility (yes/no), and presence of checklists for information supply (yes/no).
Non-responders characteristics
Telephone interviews were performed to determine the characteristics of the non-responders by asking them the five questions that were in the information letter that was sent to all possible participants. The characteristics that we compared were female age (years), previous fertility treatment (yes/no), irregular menstrual cycle (yes/no), bilateral tubal pathology (yes/no), ICSI treatment (yes/no) and socio-economic status (high/ medium/low). In order to reach as much of the selected non-responders, they were called a maximum of four times in case of no response: at least twice during daytime and twice in the evening between 5 pm and 8 pm. All Overtreatment in unexplained infertility interviews were performed using a standardized interview questionnaire and were recorded.
Data analysis
Collected data were entered in a database using the Statistical Package for the Social Sciences (SPSS 20.0 for Windows, SPSS, Inc., Chicago, IL, USA). Descriptive analyses were performed for overtreatment and the quality indicators, and were expressed as percentages (median and range on clinic level).
Descriptive analyses (frequencies and means) were also used to describe the patient and clinic characteristics. Series of multilevel univariate analysis were performed with overtreatment as the dependent variable. All patient and clinic characteristics acted separately as the independent variables. Variables with P , 0.20 in the univariate analysis were selected to perform correlation analysis with spearman's rho to evaluate collinearity between the selected characteristics. In case of two strongly correlating variables (rho . 0.6), only the clinically most relevant characteristic was included.
Subsequently, to assess the extent to which overtreatment could be explained by patient and clinic characteristics and taking clustering of data into account, multilevel multivariate regression analyses with manual backward elimination was carried out with the couple (level 1) nested within the clinic (level 2). Significance for multivariate analyses was set at P , 0.05. Figure 1 presents the recruitment of eligible participants in the study. Of the 9819 invited infertile couples with an F11 code between March 2011 and February 2012, 4283 (43%) infertile couples responded. While 855 couples refused participation or considered themselves ineligible, the other 3428 (80%) couples were willing to participate. Based on the answers to four of the questions in the information letter, 1965 couples were excluded prior to the medical record research. We excluded another 919 couples because medical record research revealed exclusion criteria. As a result, 544 infertile couples were included in the study.
Results
Study population
Non-responders
In the six selected clinics 1403 couples did not respond. We tried to contact 290 of these non-responder couples (20%) and 190 (66%) were reached and willing to participate in the telephone interviews and 142 (49%) of them answered all the additional questions necessary to assess the background characteristics. We compared those background No infertility: recurrent miscarriage, molar pregnancy, uterine myoma, extra-uterine pregnancy, preimplantation genetic diagnosis, duration of active child wish less than a year. characteristics of the non-responders to the responders in all 25 participating clinics in this study (Table I) . Two of the six characteristics showed a significant difference: non-responders more often had an irregular menstrual cycle compared with the responders (41.1 versus 28.9%, P , 0.01), and more had low socio-economic status compared with responders (20.6 versus 8.9%, P , 0.01).
Overtreatment and quality indicators
The results of overtreatment in couples eligible for TEM and the three quality indicators are shown in Fig. 2 . The overall overtreatment in the 25 clinics was 36.4%. There was a wide range of overtreatment between the clinics (16 to 81% of the couples). Couples with Overtreatment in unexplained infertility overtreatment started fertility treatment after a mean duration of 2.9 months after fertility work up was completed. The first quality indicator, not calculating the prognosis of a natural conception within 1 year, revealed that in 34.2% of all couples no prognosis was calculated, with a range from 0 to 96% between the clinics. The second quality indicator, incorrect course of treatment advised (i.e. immediate fertility treatment or an expectant management period of ,6 months), occurred in 42.3% of the couples, ranging from 14 to 76% between the clinics. The third quality indicator showed that in case a correct expectant period of at least 6 months after fertility work up was advised (n ¼ 324), the expectant period was not followed in 16.2% of these couples (n ¼ 51), ranging from 0 to 63% between the clinics. These couples started fertility treatment after a mean duration of 4.3 months after fertility work up.
The overlap of couples between the three quality indicators and overtreatment is shown in Supplementary Fig. S1 .
Outcome
Pregnancy data are shown in Table II . In the group of couples with overtreatment, 28% of couples had an ongoing pregnancy within 6 months and 42% of couples within 1 year. For couples who were not exposed to overtreatment, 31% of couples had an ongoing pregnancy within 6 months and 41% of couples within 1 year. Most of the couples with overtreatment had a pregnancy resulting from fertility treatments (90%) and most of the couples without overtreatment conceived naturally (91%).
Patient and clinic characteristics and their association with overtreatment
Patient characteristics and their association with overtreatment in univariate multilevel analysis are shown in Table III . A longer duration of infertility (per year) and nulliparity (versus primi-and multiparity) are significantly associated with more overtreatment.
Clinic characteristics and their association with overtreatment in univariate multilevel analysis are shown in Table IV . One to three gynaecologists per clinic was associated with more overtreatment compared with clinics with more than three gynaecologists (OR 1.44; 95% CI 1.0-2.1). No other characteristics were significantly associated.
The correlation analysis showed that the type of infertility (primary) and the parity (nulliparous) were highly correlated (rho . 0.6). For the multivariate multilevel analysis the type of infertility was used as independent variable since we considered that the type of infertility was more clinically relevant. The results of the multivariate multilevel analysis showed that only patient characteristics were significantly associated with overtreatment (Table V) . Couples with primary infertility have a higher risk of overtreatment compared with couples with secondary infertility (OR 1.12; 95% CI 1.02 -1.24). A longer duration of infertility (per year) increases the risk of overtreatment (OR 1.11; 95% CI 1.03 -1.20) and a higher female age (per year) is also significantly independently associated with more overtreatment (OR 1.02; 95% CI 1.00 -1.03).
Discussion
In this study, we found that over one-third of couples with unexplained infertility who were eligible for tailored expectant management, i.e. couples with a good prognosis of a natural conception, were exposed to overtreatment. Overtreatment means that a fertility treatment was started within 6 months after the fertility work up was completed. Overtreatment occurs mainly because couples are not diagnosed and identified correctly as being eligible for TEM or that the expectant period is not followed despite TEM being advised. The highest risk for overtreatment was in childless couples with a higher female age and a longer duration of infertility. Furthermore, our data on pregnancy rates underline the justification of advising TEM.
The findings in our study are congruent with literature from several countries and from other health care fields that suggest that 30 -40% of patients do not receive care based on the best available evidence and that 20-25% of provided health care is considered unnecessary and potentially harmful (Grol, 2001; Schuster et al., 2005) . Furthermore, our study shows that the development and dissemination of current clinical guidelines has not improved the adherence to TEM and that overtreatment still occurs as frequently or even more than previous studies on TEM report (van den Boogaard et al., 2011) . Extra efforts to implement guideline recommendations on TEM are necessary (Grol, 2001; Grimshaw et al., 2004; van den Boogaard et al., 2011) . In 2013, insurance companies and the Dutch government have tried to make TEM obligatory as part of a plan to improve the cost-effectiveness of fertility care. We think that to implement TEM fully, a good understanding of the factors leading to overtreatment is necessary. Our results show that a large part of the problem lies in correctly diagnosing and identifying couples who are eligible for TEM. Therefore, it is important to make doctors aware of the guideline recommendations on TEM and encourage them to calculate the prognosis for couples with unexplained infertility and advise TEM if the prognosis is good. To support doctors in taking these steps, it is important that tools will be available, such as a local protocol for TEM and providing the prognostic model with easy access.
Advising TEM to couples is in the hands of the professionals, adhering to the expectant period of at least 6 months also relies on the couple. If the couple does not believe that TEM is the best option, they can put pressure on the professional to start treatment sooner or they can try to get fertility treatment elsewhere. Our results underline that it is very important that we need to tackle the barriers for TEM on both patient and professional level (van den Boogaard et al., 2012) . More information about the calculation of the prognosis and the reason for TEM is required for couples, and doctors need tools to help them counsel patients on TEM. These tools can include a communication training on TEM and/ or a website, with the prognostic model, information on TEM, and information on ways to optimize the chance of natural conception, that can be accessed by both patients and professionals. The need for more information on the prognostic model and TEM also shows in the patient characteristics that we found to be associated with overtreatment, i.e. higher female age, a longer duration of infertility and primary infertility. Remarkably, all three associated patient characteristics are factors that are already being weighed in the calculation of the prognosis. In couples with primary infertility, the woman has not been pregnant and the pressure to start fertility treatment might be higher because their faith in their ability to conceive naturally might be less. However, it is the only characteristic that has not previously been reported to be associated with overtreatment (van den Boogaard et al., 2011) .
In contrast to findings in previous studies on TEM, we did not find any clinic characteristics to be independently significantly associated with overtreatment (van den Boogaard et al., 2011) . This might be explained by the fact that in the study that reports this, no multilevel analysis was done to correct for the clustering of couples by clinic. Our results are congruent with another study on guideline adherence in fertility care, which also performed a multilevel analysis, that showed that guideline recommendations are rarely influenced by clinic characteristics and mostly by patient characteristics (Hermens et al., 2011) .
Our study has several strengths. First, we were able to do a large national evaluation of overtreatment in couples with unexplained infertility. We were able to include 544 infertile couples from 25 clinics across the Netherlands, ensuring representativeness of the Dutch unexplained infertile population. Second, this is the first time that underlying processes that lead to overtreatment are assessed with quality indicators. Third, by including such a varied group of couples from different types of clinics we were able to do a multilevel analysis to evaluate the relationship of characteristics on both patient and clinic level to overtreatment. This will be of help to develop an implementation strategy that can target these specific characteristics to reduce overtreatment.
However, some limitations in this study should be considered. First, the response rate was lower compared with other fertility studies (Troude et al., 2012; Van Dongen et al., 2012; Huppelschoten et al., 2013) . The non-response research showed that the responders less often were women with anovulation and couples with a lower socioeconomic status. Since anovulation was an exclusion criteria, this is not expected to have influenced the results. The higher SES of the responders might not have influenced the results either, since the univariate analysis showed that SES was not associated with overtreatment. However, we cannot exclude that there might be a response bias in the non-response research as well. Second, we only looked at the steps that lead to overtreatment in a clinical setting. To what extent the couples were correctly, meaning not too soon, referred and informed on the possibility of TEM by the GP has not been measured. Third, we looked at overtreatment in Dutch fertility care and not in an international setting. Various European guidelines also make recommendations on TEM (Fields et al., 2013) . However, the incentive to start treatment might be higher in other countries because there are different reimbursement policies towards fertility care. Moreover, guidelines are well known and imbedded in Dutch fertility care, which may lead to an overestimation of guideline adherence for a broader Overtreatment in unexplained infertility perspective. More investigation is needed to assess overtreatment in other European countries and evaluate if they face the same problems concerning TEM.
In conclusion, this study showed that in the Netherlands, overtreatment occurs in over one-third of all infertile couples eligible for TEM. Meaning that there is room for improvement in guideline adherence, specifically in calculating the prognosis, advising a period of expectant management, and adhering to the expectant period. This is especially the case in childless couples with a higher female age and a longer duration of infertility. To improve future care and prevent couples from being exposed to unnecessary fertility treatment, the next step is to develop and evaluate an implementation strategy that targets this problem at multiple levels. 
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